You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Cost breakdown of the total out-of-pocket patient payments (n=367)

From: Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

  All of the febrile neutropenia episodes
Median cost (interquartile range), 2012 US$ Mean cost (95% CI), 2012 US$ Percentage breakdown
Ward 230 (145–504) 432 (375–488) 18.4%
Laboratory 171 (120–260) 314 (266–362) 13.3%
Radiology 17 (8–64) 88 (66–110) 3.7%
Prescription 507 (319–891) 829 (720–937) 35.2%
Other/Unknown 383 (226–661) 692 (585–800) 29.4%
Total 1,405 (901–2,442) 2,230 (1,976-2,483) 100%